Depression Awareness Monthly
0
  • Home
  • Latest News
  • Depression
Depression Awareness Monthly
Depression Awareness Monthly
  • Home
  • Latest News
  • Depression
Latest News

New Drug for Alzheimer Disease Shows Promise in Phase 3 Trial

Doctorslounge
Posted by Doctorslounge
Share on
READ NEXT
Key CDC Health Websites Vanish Following Trump Orders

Lecanemab is a monoclonal antibody drug designed to target and help remove Alzheimer-associated amyloid plaques in the brain

Read More

Share on
Share on Facebook Share on Twitter Share on Pinterest Share on Email
Doctorslounge
Previous Article Medicare Monthly Premiums to Drop for Seniors
Next Article Pandemic Heightened Emotional Exhaustion in Health Care Workers

ADVERTISEMENT

ADVERTISEMENT

You Might Also Enjoy

Latest News

Chronic Exposure to Systemic Inflammation May Increase Risk for Affective Disorders

Latest News

Late Childhood Screen Time May Lead to Developmental Changes in Brain

Latest News

Time-Restricted Eating Does Not Impact Sleep, Mood, Quality of Life

Latest News

FDA Will Now Require Labeling of ADHD Medication to Indicate Weight Loss Risk

Load More
Depression Awareness Monthly
  • Home
  • Latest News
  • Depression

© 2020 - 2021 Powered by eHealthcare Solutions | Privacy Policy

×